SiriusPoint appoints Susan Cross to Board of Directors, effective May 24, 2024

SiriusPoint Ltd

Board expands from 9 to 10 members with appointment of Susan Cross as Class I director.
Cross has 40+ years insurance experience; served as EVP & Global Chief Actuary at XL Group.
Current board roles include Enstar Group and Unum Group; appointment effective May 24, 2024.
Cross qualifies as independent under NYSE and SEC rules; will receive standard non-employee director compensation.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Susan Cross

Class I Director

SPNT · SiriusPoint Ltd

Effective: 2024-05-24
Filed: May 28, 2024, 7:59 PM ET

On May 24, 2024, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of SiriusPoint Ltd. (the “Company”), increased the size of the Board from nine to ten members, and appointed Susan Cross to fill the newly created vacancy, to serve as a Class I director

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Susan Cross was appointed as Class I Director at SiriusPoint Ltd.

Action: appointed
Role: Class I Director

Exact text from the filing

On May 24, 2024, upon the recommendation of its Nominating and Corporate Governance Committee, the board of directors (the “Board”) of SiriusPoint Ltd. (the “Company”), increased the size of the Board from nine to ten members, and appointed Susan Cross to fill the newly created vacancy, to serve as a Class I director

View on SEC.gov

SiriusPoint Ltd filing history →

Source: SEC EDGAR

accession 0001193125-24-148130

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.